Timothy Eugene Sullivan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Timothy Eugene Sullivan has an estimated net worth of at least $15.1 million*, as of Oct. 29, 2025. They own 212,437 shares of APLS stock. They have sold 178,706 shares of APLS stock since 2021, for an estimated $9.9 million.
Timothy Eugene Sullivan $APLS SEC Form 4 Insider Trading
Timothy Eugene Sullivan has filed a total of 23 insider trades in $APLS since 2021. Their most recent trade was a sale of 10,287 shares, made on Jan 22, 2026. Their largest trade was a sale of 32,729 shares, made on Sep 08, 2025. We estimate that they now own 212,437 shares of $APLS, worth an estimated $5.1 million.
Insider Trading at $APLS
There have been a total of 336 insider trades reported at $APLS since 2021, with 250,000 shares purchased and 2.7 million shares sold. The most active insider traders in $APLS stock have been Pascal Deschatelets, Cedric Francois, and David O. Watson. The most recent trade was a sale of 368 shares reported by Mark Jeffrey DeLong (Chief Business & Strat Officer), made on Feb 11, 2026.
History of Insider Stock Trades by Timothy Eugene Sullivan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
APLS
|
Sale | 10,287 | Jan 22, 2026 | Jan. 23, 2026, 5:07 p.m. |
|
APLS
|
Sale | 2,892 | Jan 20, 2026 | Jan. 21, 2026, 5:10 p.m. |
|
APLS
|
Sale | 3,856 | Jan 13, 2026 | Jan. 15, 2026, 5:29 p.m. |
|
APLS
|
Sale | 10,000 | Oct 21, 2025 | Oct. 23, 2025, 4:20 p.m. |
|
APLS
|
Sale | 10,000 | Sep 08, 2025 | Sept. 10, 2025, 4:02 p.m. |
|
APLS
|
Sale | 32,729 | Sep 08, 2025 | Sept. 10, 2025, 4:02 p.m. |
|
APLS
|
Sale | 546 | Jan 29, 2025 | Jan. 30, 2025, 1:15 p.m. |
|
APLS
|
Sale | 3,088 | Jan 22, 2025 | Jan. 23, 2025, 4:37 p.m. |
|
APLS
|
Sale | 1,730 | Jan 17, 2025 | Jan. 21, 2025, 5:11 p.m. |
|
APLS
|
Sale | 2,170 | Jan 13, 2025 | Jan. 14, 2025, 5:25 p.m. |
|
APLS
|
Sale | 4,000 | Apr 01, 2024 | April 2, 2024, 4:06 p.m. |
|
APLS
|
Sale | 906 | Jan 29, 2024 | Jan. 31, 2024, 5:34 p.m. |
|
APLS
|
Sale | 3,551 | Jan 22, 2024 | Jan. 23, 2024, 7:13 p.m. |
|
APLS
|
Sale | 2,235 | Jan 16, 2024 | Jan. 17, 2024, 5:36 p.m. |
|
APLS
|
Sale | 300 | Nov 30, 2023 | Dec. 1, 2023, 5:11 p.m. |
|
APLS
|
Sale | 13,858 | Nov 30, 2023 | Dec. 1, 2023, 5:11 p.m. |
|
APLS
|
Sale | 300 | Jul 03, 2023 | July 6, 2023, 4:16 p.m. |
|
APLS
|
Sale | 3,192 | Jul 03, 2023 | July 6, 2023, 4:16 p.m. |
|
APLS
|
Sale | 3,287 | Jul 03, 2023 | July 6, 2023, 4:16 p.m. |
|
APLS
|
Sale | 1,600 | Jun 05, 2023 | June 6, 2023, 4:59 p.m. |
|
APLS
|
Sale | 7,064 | Jun 05, 2023 | June 6, 2023, 4:59 p.m. |
|
APLS
|
Sale | 30,506 | Jun 05, 2023 | June 6, 2023, 4:59 p.m. |
|
APLS
|
Sale | 30,609 | Jun 05, 2023 | June 6, 2023, 4:59 p.m. |
$APLS Executives and Stock Owners with Insider Trades
-
Pascal Deschatelets, Chief Scientific Officer
-
Cedric Francois, Chief Executive Officer
-
David O. Watson, General Counsel
-
Adam J. Townsend, Chief Commercial Officer
-
Timothy Eugene Sullivan, Chief Financial Officer
-
Federico Grossi, CHIEF MEDICAL OFFICER
-
James George Chopas, VP/Chief Accounting Officer
-
Jeffrey Eisele, Chief Development Officer
-
Karen Lewis, Chief People Officer
-
Mark Jeffrey Delong, Chief Business & Strat Officer
-
Nur Nicholson, Chief Technical Officer
-
Mark Jeffrey Delong, Senior Vice President
-
Lukas Scheibler, CHIEF INNOVATION OFFICER
-
Caroline Baumal, Chief Medical Officer
-
Nicole D Perry, Vice President - Accounting
-
Federico Grossi, Chief Medical Officer
-
Lukas Scheibler, Chief Research Officer
-
Victoria L. Brown, Program Team Lead
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.